Skip to content

BMY

Bristol-Myers Squibb Company

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Operating cash flow10.7B14.2B15.2B13.9B13.1B16.2B14.1B8.2B7.1B5.3B3.1B2.1B3.1B3.5B6.9B4.8B4.5B4.1B3.7B3.2B
1.37B1.31B1.25B1.21B1.12B0.97B0.75B0.84B0.95B1.06B1.22B0.82B0.53B0.54B0.55B0.37B0.42B0.73B0.94B0.84B
Free cash flow9.3B12.8B13.9B12.7B11.9B15.2B13.3B7.4B6.1B4.2B1.8B1.3B2.6B3.0B6.4B4.5B4.1B3.3B2.8B2.3B
Depreciation and amortization2.8B4.0B9.6B9.8B10.3B10.7B10.4B1.7B637M789M626M683M829M763M681M628M744M707M816M892M
Stock-based compensation552M553M507M518M457M583M779M441M221M199M205M235M213M191M154M161M193M183M181M133M
Buybacks—005.16B8.00B6.29B1.55B7.30B0.32B2.47B0.23B——0.43B2.40B1.22B0.58B———
Dividends paid5.12B5.05B4.86B4.74B4.63B4.40B4.08B2.68B2.61B2.58B2.55B2.48B2.40B2.31B2.29B2.25B2.20B2.48B2.46B2.21B
Dividends per share2.522.492.422.312.192.011.841.681.611.571.531.491.451.411.371.331.291.251.241.15
Free cash flow margin18.6%26.7%28.9%28.1%25.9%32.8%31.3%28.2%27.1%20.3%9.5%7.8%16.5%18.4%36.3%21.1%20.9%17.7%15.6%14.8%